“Laboratory assessment of liver function in people starting antiretroviral therapy with Dolutegravir or Efavirenz: a cohort study in Belo Horizonte, Brazil”, RSD, vol. 11, no. 13, p. e74111335082, Sep. 2022, doi: 10.33448/rsd-v11i13.35082.